Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christine B. Mackay
Observed names:
C. Mackay,
Christine Mackay,
Mackay, Christine
Institution:
University of Kansas Medical Center
Observed institutions:
University of Kansas,
The University of Kansas Cancer Center,
GlaxoSmithKline (United States),
University of Kansas Medical Center
ORCID:
0000-0002-1582-346X
Observed ORCID:
0000-0002-1582-346X
OpenAlex ID:
A5015069511
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies
2015
·
Stephen K. Williamson
, Gary A. Johnson
, et al.
·
Cancer Chemotherapy and Pharmacology
·
80
Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices
2019
·
Shellie Ellis
, Mugur Geana
, et al.
·
Trials
·
35
PDF
Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate
2017
·
Christine B. Mackay
, Kaitlyn R. Antonelli
, et al.
·
Cancer
·
23
PDF
Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices
2019
·
Shellie D. Ellis
, Mugur Geana
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
20
Giant PMMA foreign body granulomas with imaging
2023
·
Sunthosh Sivam
, Christine Mackay
, et al.
·
Journal of Cutaneous and Aesthetic Surgery
·
13
Clinical trial insurance coverage for cancer patients under the Affordable Care Act
2015
·
Christine B. Mackay
, Tami Gurley-Calvez
, et al.
·
Contemporary Clinical Trials Communications
·
9
PDF
Who treats lung cancer? Results from a global survey
2017
·
Takefumi Komiya
, Christine B. Mackay
, et al.
·
Respiratory Investigation
·
5
Status of oncologic specialties: global survey of physicians treating cancer
2016
·
Takefumi Komiya
, Christine B. Mackay
, et al.
·
International Journal of Clinical Oncology
·
4
Use of a theoretical framework to examine declines in clinical trial enrollment.
2019
·
Christine B. Mackay
, Kerry Hepler
, et al.
·
Journal of Clinical Oncology
·
1
Predictors of insurance denials for cancer clinical trial participation after ACA mandate.
2016
·
Christine B. Mackay
, Kaitlyn Antonelli
, et al.
·
Journal of Clinical Oncology
·
1
MM-404 Real-World Belantamab Mafodotin Use: A US Retrospective Longitudinal Pharmacy and Medical Open-Source Claims Database Assessment
2022
·
Natalie Boytsov
, Karen M. Stockl
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Poster: MM-404 Real-World Belantamab Mafodotin Use: A US Retrospective Longitudinal Pharmacy and Medical Open-Source Claims Database Assessment
2022
·
Natalie Boytsov
, Karen M. Stockl
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P-234: Real-world belantamab mafodotin (belamaf) use: a US retrospective longitudinal pharmacy and medical open-source claims database assessment
2022
·
Natalie Boytsov
, Karen M. Stockl
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Recording Patient Assessment for Clinical Trial Participation: A Study of Radiation Oncologists Across a Single Healthcare System
2019
·
C. Mackay
, T. Gurley-Calvez
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Identifying patients for clinical trials: Evaluation of NCI-designated community cancer centers.
2016
·
Christine B. Mackay
, Kerry Hepler
, et al.
·
Journal of Clinical Oncology
A Phase I Trial of Irinotecan (Iri) and Buparlisib in Previously Treated Patients (Pts) with Metastatic Colorectal Cancer (Mcrc): Final Results
2014
·
J.C. Baranda
, G. Reed
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
19
Citation count:
191
H-index:
6
I10-index:
5
Year
Topic
Type